AG

Artal Group Portfolio holdings

AUM $930M
1-Year Return 3.57%
This Quarter Return
-1.59%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.07B
AUM Growth
-$328M
Cap. Flow
+$67.8M
Cap. Flow %
1.67%
Top 10 Hldgs %
46.29%
Holding
163
New
17
Increased
15
Reduced
14
Closed
15

Top Buys

1
ERAS icon
Erasca
ERAS
$67.3M
2
SGEN
Seagen Inc. Common Stock
SGEN
$63.7M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$61.9M
4
OMGA
Omega Therapeutics, Inc. Common Stock
OMGA
$42.9M
5
CYTK icon
Cytokinetics
CYTK
$28.6M

Top Sells

1
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$72.6M
2
XLRN
Acceleron Pharma Inc.
XLRN
$68.8M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$38.8M
4
SEER icon
Seer Inc
SEER
$28.9M
5
TRIL
Trillium Therapeutics Inc.
TRIL
$24.3M

Sector Composition

1 Healthcare 90.53%
2 Consumer Discretionary 7.15%
3 Consumer Staples 0.56%
4 Materials 0.44%
5 Financials 0.34%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALXO icon
26
ALX Oncology
ALXO
$64.8M
$36.9M 0.83%
500,000
– –
NTLA icon
27
Intellia Therapeutics
NTLA
$1.27B
$36.9M 0.83%
275,000
+25,000
+10% +$3.35M
BLU
28
DELISTED
BELLUS Health Inc.
BLU
$32.2M 0.72%
5,250,000
+500,000
+11% +$3.07M
GOSS icon
29
Gossamer Bio
GOSS
$664M
$29.7M 0.66%
2,358,968
– –
AGEN
30
Agenus
AGEN
$134M
$28.9M 0.65%
280,225
-25,475
-8% -$2.63M
TRML icon
31
Tourmaline Bio
TRML
$710M
$28M 0.63%
206,426
– –
KRON
32
DELISTED
Kronos Bio
KRON
$27.6M 0.62%
1,317,954
– –
ATRA icon
33
Atara Biotherapeutics
ATRA
$89.1M
$26.9M 0.6%
60,000
– –
ITOS
34
DELISTED
iTeos Therapeutics
ITOS
$26.8M 0.6%
994,047
– –
REPL icon
35
Replimune Group
REPL
$482M
$26.7M 0.6%
900,000
– –
TGTX icon
36
TG Therapeutics
TGTX
$5.01B
$26.6M 0.6%
800,000
– –
PTGX icon
37
Protagonist Therapeutics
PTGX
$3.71B
$26.6M 0.59%
+1,500,000
New +$26.6M
KRYS icon
38
Krystal Biotech
KRYS
$4.4B
$26.1M 0.58%
500,000
– –
DNLI icon
39
Denali Therapeutics
DNLI
$2.26B
$25.2M 0.56%
500,000
– –
FHTX icon
40
Foghorn Therapeutics
FHTX
$322M
$24M 0.54%
1,720,720
– –
KYMR icon
41
Kymera Therapeutics
KYMR
$3.11B
$23.5M 0.53%
400,000
+150,000
+60% +$8.81M
TPTX
42
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$23.3M 0.52%
350,000
– –
FMTX
43
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$23.2M 0.52%
1,000,000
– –
SQZ
44
DELISTED
SQZ Biotechnologies Company
SQZ
$23.2M 0.52%
1,606,309
– –
OTLY
45
Oatly Group
OTLY
$524M
$22.7M 0.51%
75,000
– –
PRAX icon
46
Praxis Precision Medicines
PRAX
$971M
$22.2M 0.5%
80,000
– –
AUPH icon
47
Aurinia Pharmaceuticals
AUPH
$1.64B
$22.1M 0.5%
1,000,000
– –
KURA icon
48
Kura Oncology
KURA
$720M
$19.7M 0.44%
1,050,000
+450,000
+75% +$8.43M
IMA
49
ImageneBio, Inc. Common Stock
IMA
$96.3M
$19.6M 0.44%
129,126
– –
TSHA icon
50
Taysha Gene Therapies
TSHA
$892M
$19.4M 0.43%
1,040,882
– –
1
2
3 4 5